• OPEN AN ACCOUNT
Indian Indices
Nifty
25,541.80 24.75
(0.10%)
Sensex
83,697.29 0.00
( 0.00%)
Bank Nifty
57,459.45 146.70
( 0.26%)
Nifty IT
38,833.15 -116.85
( -0.30%)
Global Indices
Nasdaq
44,512.09 396.31
(0.90%)
Dow Jones
6,218.43 -7.52
(-0.12%)
Hang Seng
39,928.49 -558.90
(-1.38%)
Nikkei 225
8,785.33 24.37
(0.28%)
Forex
USD-INR
85.62 0.21
(0.25%)
EUR-INR
100.54 0.47
(0.47%)
GBP-INR
117.42 0.25
(0.22%)
JPY-INR
0.59 0.00
(0.57%)

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
532331
INE031B01049
290.2218799
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AJANTPHARM
34.55
31297.98
EPS(TTM)
Face Value()
Div & Yield %
72.53
2
1.12
 

vedanta ltd
Qgo Finance standalone net profit declines 13.64% in the March 2025 quarter
May 27,2025
Net profit of Qgo Finance declined 13.64% to Rs 0.76 crore in the quarter ended March 2025 as against Rs 0.88 crore during the previous quarter ended March 2024. Sales rose 8.31% to Rs 4.04 crore in the quarter ended March 2025 as against Rs 3.73 crore during the previous quarter ended March 2024.

For the full year,net profit rose 15.85% to Rs 3.07 crore in the year ended March 2025 as against Rs 2.65 crore during the previous year ended March 2024. Sales rose 16.73% to Rs 16.40 crore in the year ended March 2025 as against Rs 14.05 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales4.043.73 8 16.4014.05 17
OPM %90.1091.96 -88.5488.97 -
PBDT1.031.09 -6 4.323.57 21
PBT0.840.95 -12 4.023.36 20
NP0.760.88 -14 3.072.65 16